Levetiracetam Ciclum Farma

Levetiracetam, the active ingredient in Levetiracetam Ciclum Farma, is an anticonvulsant presented as an oral tablet for oral use. It is used to treat various seizure types in patients with epilepsy. GNH USA supplies Levetiracetam Ciclum Farma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that acts on neuronal excitability to control seizure activity.

Partial‑onset seizures: reduces frequency and severity of focal seizures. Myoclonic seizures: diminishes sudden muscle jerks associated with myoclonic epilepsy. Primary generalized tonic‑clonic seizures: helps prevent loss of consciousness and convulsive episodes in generalized epilepsy.

Levetiracetam may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Dizziness - Fatigue - Somnolence - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or severe skin reactions - Severe allergic reactions (anaphylaxis) - Mood changes, including depression or suicidal thoughts - Blood dyscrasias (e.g., neutropenia) - Hepatic dysfunction - Severe respiratory depression when combined with other CNS depressants

Before initiating therapy, clinicians should consider several safety aspects.

Renal impairment: adjust dose based on creatinine clearance. Hepatic function: monitor liver enzymes in patients with liver disease. Concomitant CNS depressants: use caution due to additive sedation. Pregnancy: risk unknown; weigh benefits against potential fetal exposure. Driving and machinery: avoid until individual response is known. Store at ambient temperature: keep in original packaging, protect from moisture and light.

Levetiracetam can interact with other medications, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenytoin: may decrease levetiracetam exposure. - Phenobarbital: can lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam levels. - Other CNS depressants (e.g., benzodiazepines): enhanced sedation. - Alcohol: may potentiate central nervous system effects.